Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Conatus Pharmaceuticals Inc.
With
Idun Pharmaceuticals
The occurrence of apoptosis in liver ischemia/reperfusion injury has been well characterized in animal models. In this context apoptosis has specifically been observed in sinusoidal endothelial cells and hepatocytes, and this has also been associated with an increase in activated caspase-3 in liver tissue extracts. The use of caspase inhibitors to prevent apoptosis during liver storage and transplantation may reduce ischemia/reperfusion injury and hence improve graft function after transplantation. Suppression of apoptosis by caspase inhibitors may also allow for longer ischemic times allowing organs to be transported greater distances. In addition, suppression of apoptosis may lower the risk involved in using suboptimal donor organs.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Minimum adult age
You may not be if
Fulminant hepatic failure (UNOS Status I patients)